Related topics

Novavax: Q4 Earnings Snapshot

February 28, 2023 GMT

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Tuesday reported a loss of $182.2 million in its fourth quarter.

On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $2.28.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.

The vaccine maker posted revenue of $357.4 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $377.6 million.

For the year, the company reported that its loss narrowed to $657.9 million, or $8.42 per share. Revenue was reported as $1.98 billion.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NVAX at